Film Shines Spotlight on Stanford Women’s Cancer Center

In 2011, the Stanford Women’s Cancer Center opened its doors with the goal to pioneer innovations and discoveries in breast and gynecologic cancer treatment. Since that time, the center has guided a new era of cancer research with major breakthroughs including clinical trials that led to FDA approval for three PARP inhibitors; genetic testing methods that result in earlier treatment; and the discovery of CD47 and the anti-CD47 antibody, which shows promise for cancer immunotherapies. These leading-edge therapies are impressive and demonstrate the power of research when directly applied to clinical trials.

Stanford Women’s Cancer Center is undoubtedly changing cancer care, but most importantly, it is improving outcomes for patients looking to reclaim their lives. Behind the research is a breast cancer survivor named Beverly; a mom, Lori, who overcame fallopian tube cancer; and many more profound patient stories that bring meaning to the work done at the center.

In a recent short film, Discovery and Hope, produced by Stanford Medicine, George Sledge, MD, professor and chief of oncology, describes his patients as “personal heroes.” Many come to Stanford Medicine after undergoing rounds of chemotherapy only to find their cancer has returned. At this point, Sledge says, a patient is “literally putting her life in your hands…and the amount of courage that takes is astounding.” Patients understand that clinical trial results are not certain, yet many are passionate about helping future generations and ensuring their children are not affected by the disease. This is why cancer survivor Lori says it is “very important that the research keep going.”

Watch the film below to learn more about Lori, Beverly and others who are deeply impacted by the scope of work done at Stanford Women’s Cancer Center.